NCT03109574View on ClinicalTrials.gov

Access in Dialysis for Better Outcomes in Patient Therapy

NACompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

August 29, 2016

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Central Venous CatheterCatheter-Related Bloodstream Infection (CRBSI) Nos
Interventions
DEVICE

BioFlo DuraMax Chronic Hemodialysis Catheter

DEVICE

Standard of Care Catheter

Trial Locations (3)

L6R 3J7

William Osler Health System, Brampton

L6M 0L8

Halton Healthcare, Oakville

L2S 0A9

Niagara Health System, St. Catharines

Sponsors

Collaborators (1)

Angiodynamics, Inc.
All Listed Sponsors
collaborator

Angiodynamics, Inc.

INDUSTRY

lead

William Osler Health System

OTHER

NCT03109574 - Access in Dialysis for Better Outcomes in Patient Therapy | Biotech Hunter | Biotech Hunter